Bill Text: NY A07581 | 2017-2018 | General Assembly | Introduced
Bill Title: Excludes outpatient blood clotting factor products, and other related services and treatments from managed care coverage for medical assistance recipients.
Spectrum: Partisan Bill (Democrat 3-0)
Status: (Introduced - Dead) 2017-06-15 - substituted by s5774 [A07581 Detail]
Download: New_York-2017-A07581-Introduced.html
STATE OF NEW YORK ________________________________________________________________________ 7581 2017-2018 Regular Sessions IN ASSEMBLY May 3, 2017 ___________ Introduced by M. of A. GOTTFRIED -- read once and referred to the Committee on Health AN ACT to amend the social services law, in relation to excluding outpa- tient blood clotting factor products and related services and treat- ments from coverage by managed care provided to medical assistance recipients The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Subdivision 3 of section 364-j of the social services law 2 is amended by adding a new paragraph (d-3) to read as follows: 3 (d-3) Outpatient blood clotting factor products, and other treatments 4 and services furnished in connection with the care of hemophilia and 5 other blood clotting protein deficiencies shall not be provided to 6 medical assistance recipients through managed care programs established 7 pursuant to this section, and shall continue to be provided outside of 8 managed care programs and in accordance with applicable reimbursement 9 methodologies. 10 § 2. This act shall take effect immediately; provided, however, that 11 the amendments to subdivision 3 of section 364-j of the social services 12 law made by section one of this act shall not affect the repeal of such 13 subdivision and shall be deemed to repeal therewith. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD11253-01-7